A Beacon of Hope: China's Rising ADC Innovations Lighting the Path for Cancer Fighters in 2025 | #china ADC pipeline # 2025 ADC approvals # antibody-drug conjugates cancer # HER2-positive breast cancer treatments # NSCLC targeted therapies # ovarian cancer innovations # endometrial cancer ADCs # Kelun-Biotech Jiataile # RemeGen Aidixi # Enhertu first-line treatment # trastuzumab deruxtecan # datopotamab deruxtecan # raludotug deruxtecan # rinatabart sesutecan # SystImmune iza-bren # oncology advancements 2025
Like
Comment
Share
